Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Thomas J. Brock is a CFA and CPA with more than 20 years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results